CMS Enforcement With Respect to Issuers and Non-Federal Governmental Plans—Civil Money Penaltiesdoi:CFR 2021 TITLE45 VOL2 Subtitle A SUBCHAPTER B PART 150 Subpart C
[26] In addition, manufacturers are subject to significant civil monetary penalties (CMPs) for non-compliance. Failure to honor the MFP, for example, will result in a penalty equal to 10 times the difference between the actual price charged and the MFP. CMS intends to use the net price, ...
The termination date is the earlier of the first day that the Selected Drug is no longer a Selected Drug or the date that the Agreement is terminated by either party. Participating manufacturers may be subject to civil monetary penalties and an excise “tax...
CMS with authority to correct misclassifications on behalf of a manufacturer and impose additional penalties for drug misclassification, including suspension of the misclassified drug from the MDRP, termination of the manufacturer’s participation in the MDRP, and impositi...
including any entity licensed or meeting standards for licensing as a hospital other than federally owned or operated hospitals. If CMS determines a hospital is noncompliant, the hospital could be required to follow a corrective action plan or face civil monetary penalties (CMPs) of $300 per day...
penalties for noncompliance may not exceed US$300 per day. In finalizing its price transparency policies as proposed, CMS increases the dollar amount of a Civil Monetary Penalty (CMP) it may impose on a hospital for noncompliance. Beginning 1 January 2022, ...
(FCA) liability and the concomitant penalties associated with FCA litigation and settlements. Providers may be liable under the FCA for up to three times the value of the claims submitted and per-claim penalties that increase annually with inflation, among other potential civil monetary penalties. ...
CMS may impose civil monetary penalties ranging from $1,176 to $11,766, for each payment or other transfer of value or each ownership or investment interest, as applicable, that is not appropriately reported, up to an annual limit of $176,495 (as adjusted ...
Our Hong Kong legal adviser, Latham & Watkins LLP, has also advised us that Hong Kong has no statutory arrangement for the reciprocal enforcement of judgments with the United States although it may be possible for a civil action to be brought in Hong Kong based on a monetary judgment of ...
misclassifications on behalf of a manufacturer and impose additional penalties for drug misclassification, including suspension of the misclassified drug from the MDRP, termination of the manufacturer’s participation in the MDRP, and imposition of civil monetary penaltie...